MONITORING CONTROLLED ENVIRONMENTS Pacific BioLabs Inc. (510) 964-9000

Slides:



Advertisements
Similar presentations
Environmental Monitoring Considerations
Advertisements

Microbiological Validation
WHO - PSM Water –part 3 Workshop on GMP and Quality Assurance of HIV products Shanghai, China 28 Feb - 4 March 2005 Maija Hietava M.Sci.Pharm Quality Assurance.
Sterile Product Manufacturing
User requirements of a comprehensive ENVIRONMENTAL MONITORING software system Susan B. Cleary.
WHO - PSM Air Handling Systems Heating Ventilation and Air Conditioning (HVAC) – Part 1 Pharmaceutical Quality, Good manufacturing Practice & Bioequivalence.
World Health Organization
1 Utility Systems Process Systems – ‘Direct Impact Systems’ Contact the Product Contact Materials that will Ultimately Become Part of the Product Could.
Heating Ventilation and Air Conditioning (HVAC) – Part 3
Sterile Drug Process Inspections
Facility Design and CGMP Considerations for Cell Therapy Products
SANITARY DESIGN PRINCIPLES FOR FACILITIES. ZONES OF CONTROL.
VALIDATION OF HVAC SYSTEMS
Basic Principles of GMP
SELECTING AND MANAGING CONTRACT STERILIZERS AND TESTING LABORATORIES
MCC PRESENTATION - GMP MANUFACTURING ENVIRONMENTS
Department of Quality Assurance Maliba Pharmacy College
Rob Packard, President Slide 1 of 23 Bioburden Failure Analysis An E. coli strain being plated for identification.
Rob Packard, President Slide 1 of 30 Bioburden Failure Analysis An E. coli strain being plated for identification.
Water | Slide 1 of 16 January 2006 Water for Pharmaceutical Use Part 4: Commissioning, Qualification and validation Supplementary Training Modules on Good.
World Health Organization
Qualification of HVAC systems
Preventing Contamination: Aseptic Processing Risk Factors Richard L. Friedman, M.S. FDA/CDER 10/22/02 OPS Advisory Committee/ Aseptic Processing.
MCC PRESENTATION - GMP MANUFACTURING ENVIRONMENTS
Radiopharmaceutical Production
Process Simulation Media Fills
World Health Organization
Future Editions This manual, future additions and the latest updates are available at the following website:
Basic Principles of GMP
Part 3: Design, qualification
HYGIENE CONTROL IN THE BREWING INDUSTRY WITH REFERENCE TO AIR SAMPLING FOR BACTERIA AND PARTICLE CONTROL Environmental monitoring in the Food and Beverage.
Presented by Steven P. Feltman Food Safety and Quality Specialist.
IPQC: Definition:- Checks performed during production in order to monitor and, if necessary, to adjust the process to ensure that the product conforms.
World Health Organization
© Pharmaceutical Consultancy Services, All rights reserved. ENVIRONMENTAL MONITORING (VIABLES) Jaap Koster 1.
Part I: Introduction and overview
Compounding Issues in Neuromodulation December 9, 2012 North American Neuromodulation Society 16 th Annual Scientific Meeting Wynn Hotel, Las Vegas Nevada.
Horizontal Laminar Air Flow Vertical Laminar Air Flow.
© Pharmaceutical Consultancy Services, All rights reserved. MEDIA FILLS Jaap Koster.
© Pharmaceutical Consultancy Services, All rights reserved. MEDIA FILLS Jaap Koster.
Basics of Contamination Control
Effective Sanitation 1. GMPs SANITARY EQUIPMENT DESIGN SANITARY FACILITY DESIGN HACCP TRAINED EMPLOYEES VALIDATED & VERIFIED PROCESSES REPEATABLE FOOD.
Moderated By Eyal Rivlin Lev Hakongressim, Weizmann Science Park, Ness Ziona May 2008.
Sample collection & submission, chain of custody, choosing the right test for Microbiological testing.
Expectations for Facilities & cGMPs Biological Response Modifiers Advisory Committee Meeting October 9, 2003 Nicholas Obiri, Ph.D. CBER.
PHARMACY IV ADMIXTURE Pharmacy 483 January 18, 2005 Kim Donnelly Affiliate Associate Professor.
Problem Management Scenario # 2 September 17,2005.
FDA Preliminary Concept Paper Sterile Drug Products Produced by Aseptic Processing This presentation summarizes the content of PDA’s official position,
Pharmaceutical Quality Control & current Good Manufacturing Practice PHT 436 Lecture 4.
Environmental Control and Developing a Science-based Monitoring Program Richard L. Friedman, M.S. FDA/CDER.
Wyeth-Ayerst Pharmaceuticals1 CLEANING VALIDATION Microbial Monitoring Anthony M. Cundell Ph. D. Associate Director, QA Microbiological Development & Statistics.
Sterile Products Lab PHT 434
USP <1116> and its impact on Microbiology
World Health Organization
USP 800 Implementation in a Community Oncology Practice
Pharmaceutical Quality Control & current Good Manufacturing Practice
Environmental Control & Support Processes
Author: Nurul Azyyati Sabri
Quality Control and Assurance
FDA Guide To Aseptic Processing
Author: Nurul Azyyati Sabri
Author: Nurul Azyyati Sabri
Water for Pharmaceutical Use
Quality Systems in a Production Facility
Gene Therapy Production Facility Considerations
Sterile Products Lab PHT 434
World Health Organization
Manufacture of Sterile Medicinal Products: Practical Examples
Manufacture of Sterile Medicinal Products: ‘Annex 1’ - DRAFT
Presentation transcript:

MONITORING CONTROLLED ENVIRONMENTS Pacific BioLabs Inc. (510)

2 CONTROLLED AREA Manufacturing area where non-sterile product and in process material contact equipment surfaces or are exposed to the environment Viable and nonviable contaminants are controlled to specific levels Class 100,000 and Class 10,000

3 CRITICAL AREA Aseptic processing area where sterile products/components are exposed to the environment and no further processing will occur Class 100

4 ROOM CLASSIFICATION (CLASS NAMES) ISOUS FS 209EUSP SI 31M M M ,000M ,000M ,000M 6.5

5 ROOM CLASSIFICATION LIMITS IN PARTICLES > 0.5µm ISOUS FS 209EISO (m 3 )FS 209E (ft 3 ) , ,00035,2001, ,000352,00010, ,0003,520,000100,000

6 BUILDING Sufficient space to allow  proper cleaning, maintenance, and manufacturing functions  orderly operations  contamination control Sealed windows, flush surfaces Changing rooms/washing facilities

7 BUILDING (cont.) Clean utilities such as gasses, water HVAC system Filtration of air – HEPA’s Airflow from critical to less critical areas Air lock to maintain positive pressure

8 ENVIRONMENT/HVAC SYSTEM VALIDATION HVAC air velocity, airflow patterns HEPA filter integrity and efficiency Air pressure differentials  0.04 to 0.06 inches of water gauge Cleaning and sanitization/disinfection studies Airborne non-viable particle counts Airborne viable particle counts

9 EXAMPLE ( Specifications for a medical device assembly facility Class10,000 Particles > 0.5µmGuess ?? Air Pressure0.05 inches of water Temperature °F Air Velocity90 feet/minute

10 REGULATORY BASIS FOR ENVIRONMENTAL MONITORING CFR GMP regulations FDA Guidance Documents USP Informational Chapter

11 ENVIRONMENTAL CONTROL 21 CFR (c) “Where environmental conditions could reasonable be expected to have an adverse effect on product quality, the manufacturer shall establish and maintain procedures to adequately control these environmental conditions”

12 ENVIRONMENTAL MONITORING COMPONENTS Non-Viable Particles  Air Microbial Contamination  Air  Surface Pressure Differential Water quality Temperature and Humidity

13 PRODUCT BIOBURDEN Does not have to be part of an environmental monitoring program Test performed on a non-sterile product to determine its microbial load Reflects the quality control of manufacturing process and raw materials Needed to verify adequacy of sterilization process

14 ENVIRONMENTAL CONTROL 21 CFR (c) An uncontrolled environment may result in inconsistent bioburden levels Bioburden spikes may exceed the sterilization process capability to achieve the desired SAL

15 MICROBIAL IDENTIFICATION USP  An environmental monitoring program should include identification of the flora obtained from sampling. ANSI/AAMI/ISO TIR 15843:2000  Characterization of bioburden is required to reduce the frequency of dose audits

16 ENVIRONMENTAL MONITORING PROGRAM Documented in SOP Details procedures used for monitoring Includes sampling sites Specifies sampling frequency Describe investigation when Alert or Action levels are exceeded Describes methods for trend analysis Training

17 AIRBORNE PARTICULATE COUNT AKA total particulate count Detection of particles > 0.5 µm (outside of US particles > 5.0 µm are counted) Monitoring is recommended during operations Optical particle counting equipment is commonly used

18 MICROBIAL MONITORING Assess the effectiveness of sanitization practices and of personnel Provides sufficient information to ascertain that the environment is controlled Is conducted during normal operations

19 MICROBIAL MONITORING Room air Compressor air Surfaces  Equipment  Sanitization containers  Floors  Walls  Personnel garments

20 Airborne Viable Particulate Count - Methods Passive monitoring  Settling plates  Not generally recommended in US Active monitoring  Solid culture medium impaction  Testing of known volumes of air that allow quantification by unit of volume air

21 AIRBORNE VIABLE PARTICULATE COUNT - EQUIPMENT Passive air monitoring  Petri dish with agar Active air monitoring  Slit-to-Agar (STA)  Sieve Impactors  Centrifugal Impactors  Filtration  Liquid Impingement  Gelatin Filter Sampler

22 SURFACE MICROBIAL MONITORING METHODS Contact Plates Flexible Films Swabs Surface Rinse Methods

23 PERSONNEL MONITORING Garments  Chest  Sleeves  Other areas are sampled for qualification Gloves  Finger impressions

24 EXAMPLE OF SAMPLING SITES SystemSite Environmental air (filling)Near open containers Room airProximal to work areas WaterPoint of use Surface (facility)Floor, door handles, walls Surface (equipment)Filling line, control panels Compressed airFarthest from compressor Laminar air flowNear high activity areas OperatorFinger impressions

25 SAMPLING FREQUENCY Sampling AreaFrequency Class 100 or lessEach shift Class 10,000Each shift Some support areasTwice/week Product/container contact areasTwice/week Other support areas > Class 100,000 Once/week

26 TRAINING PROGRAM Personal hygiene/habits Illness Clothing/gowning practices Introduction to microbiology GMPs Introduction to aseptic techniques Participation in media fills to demonstrate aseptic skill level Must be documented

27 ALERT AND ACTION LEVELS Alert Level  A level than when exceeded indicates a process may have drifted from its normal operating condition. Warning that does not warrant a corrective action Action Level  A level than when exceeded indicates a process has drifted from its normal operating condition. Documented investigation and corrective action required

28 AIR - ACTION LEVELS ClassCFU/m 3 CFU/ft 3 100< 3< ,000< 20< ,000< 100< 2.5

29 EQUIPMENT/FACILITIES SURFACE – ACTION LEVELS ClassCFU per Contact Plate 1003 (including floor) 10, (floor)

30 PERSONNEL GEAR SURFACE – ACTION LEVELS Class Gloves (cfu/plate) Clothing (cfu/plate) ,

31 ACTION LEVEL INVESTIGATIONS Review of:  Maintenance records  Sanitization documentation  Operational parameters Identification of microbial contaminants Training of personnel

32 CORRECTIVE ACTIONS Training of personnel Additional sampling Increased frequency of sampling Additional sanitization Additional product testing Evaluation of the need to revise SOPs Product impact/disposition documented

33 WATER REQUIREMENTS TestWFIPurifiedPotable TOC500 ppb None ConductivitySee USP None Microbial10 CFU/100mL100 CFU/mL500 CFU/mL Endotoxin0.25 EU/mLNone

34 WATER SYSTEM MONITORING FREQUENCY TestWFI SystemPurified Water EndotoxinDaily *None MicrobialDaily *Weekly TOCWeekly ConductivityWeekly

35 ENVIRONMENTAL MONITORING SURVEILLANCE SUPPORT Alert and Action Levels Data Management  Collection, trend analysis and interpretation Isolates Characterization Investigation/Corrective Actions Documentation

36 REFERENCES “Fundamentals of Environmental Monitoring”, Supplement TR 13, PDA J. Pharm. Sci. & Tech. 55(6), United Stated Pharmacopeia 30, Microbiological Evaluation of Clean Rooms and Other Controlled Environments. The United States Pharmacopeia Convention Inc., Rockville, MD. pp (2007). United Stated Pharmacopeia 30, Pharmaceutical Compunding-Sterile Preparations. The United States Pharmacopeia Convention Inc., Rockville, MD. pp (2007). United States Food and Drug Administration “Medical Device Quality Systems Manual” (January 1997).

THANK YOU Q & A